# Yanhua Smartech Group to acquire 45% stake in Beijing Taihekang Medical Bio-Technology

Yanhua Smartech Group plans to buy a 45% stake in Beijing Taihekang Medical Bio-Technology, a supplier of in-vitro diagnosis products to Abbott Laboratories, for CNY 184.5 million (USD 26.2 million).

- Type: Acquisition
- Announced: 2019-11-01
- Where: Beijing, China
- Value: $26.2M (184.5M CNY)
- Status: announced
- Products: in-vitro diagnosis products, clinical immune system diagnosis devices, reagents, consumables
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Yanhua Smartech Group](https://endata.com/companies/43040.md) (acquirer)
- [Beijing Taihekang Medical Bio-Technology](https://endata.com/companies/43041.md) (target)

## Sources

- [yicaiglobal.com](https://www.yicaiglobal.com/news/yanhua-smartech-to-take-45-stake-in-abbot-laboratories-ivd-supplier), 2019-11-01: "Yanhua Smartech Group plans to buy a 45 percent share of a Chinese firm that supplies in-vitro diagnosis products to Abbot Laboratories as it looks expand its portfolio of services."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.